Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China flag China · Delayed Price · Currency is CNY
26.65
+0.04 (0.15%)
Nov 18, 2026, 3:00 PM CST

Yifeng Pharmacy Chain Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,3083,0813,5793,5664,1132,921
Short-Term Investments
-163.6120.52---
Trading Asset Securities
5,2405,8544,4071,63150.05152.19
Cash & Short-Term Investments
9,5499,0988,0065,1974,1633,073
Cash Growth
17.69%13.64%54.07%24.84%35.46%-25.22%
Accounts Receivable
1,5361,9852,1532,1501,8461,087
Other Receivables
432.69501.42477.94448.54419.47323.6
Receivables
1,9692,4862,6312,5992,2651,411
Inventory
4,0464,6374,5283,8083,6153,041
Prepaid Expenses
-30.4837.16--35.17
Other Current Assets
605.12573.74652.9525.62535.91356.71
Total Current Assets
16,16916,82615,85612,12910,5787,916
Property, Plant & Equipment
4,2884,7175,6795,6654,8924,504
Long-Term Investments
175.66133.59530.22592.97334.096.72
Goodwill
4,7794,7654,7694,6114,1883,718
Other Intangible Assets
453.03480.91483.09470.97478.2389.25
Long-Term Deferred Tax Assets
122.09129.54148.62138.67127.68109.79
Long-Term Deferred Charges
358.21387.72493.88499.14430.69379.59
Other Long-Term Assets
11.0212.2515.1730.277.2328.39
Total Assets
26,35627,45227,97524,13721,03617,052

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7,8058,8309,4928,1716,7614,806
Accrued Expenses
432.7632.01587.26549.68683.11390
Short-Term Debt
--30.03---
Current Portion of Long-Term Debt
1,0317.4666103.4892.924.21
Current Portion of Leases
-1,1411,2711,3551,185931.44
Current Income Taxes Payable
396.52301.88207.1165.76176.87148.83
Current Unearned Revenue
170.34228.52130.0780.1760.6941.1
Other Current Liabilities
529.8612.08814.24844.45700.13424.11
Total Current Liabilities
10,36611,75312,59811,2699,6596,745
Long-Term Debt
1,6841,6511,601133.62228.67365.65
Long-Term Leases
1,3641,6052,3132,2061,9512,024
Long-Term Unearned Revenue
52.8653.1953.6354.0954.6950.34
Long-Term Deferred Tax Liabilities
36.5311.3515.4126.7623.712.16
Total Liabilities
13,50315,07316,58113,68911,9179,187

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,2121,2121,2121,011721.7718.77
Additional Paid-In Capital
3,6513,5483,5453,7163,9913,988
Retained Earnings
7,0926,5505,6934,9733,8492,802
Treasury Stock
-96.42--3.76-42.24-77.41-27.76
Comprehensive Income & Other
161.88324.39278.95147.9368.34-
Total Common Equity
12,02011,63410,7269,8048,5537,481
Minority Interest
832.38744.32667.88642.66565.39383.24
Shareholders' Equity
12,85312,37911,39410,4479,1197,865
Total Liabilities & Equity
26,35627,45227,97524,13721,03617,052

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4,0804,4045,2813,7983,4583,325
Net Cash (Debt)
5,4694,6942,7251,399705.02-252.57
Net Cash Growth
60.42%72.25%94.78%98.44%--
Net Cash Per Share
4.423.802.211.160.58-0.21
Filing Date Shares Outstanding
1,2081,2121,2121,2131,2121,208
Total Common Shares Outstanding
1,2081,2121,2121,2131,2121,208
Working Capital
5,8035,0733,258859.44918.951,171
Book Value Per Share
9.959.608.858.087.056.20
Tangible Book Value
6,7886,3885,4744,7233,8873,374
Tangible Book Value Per Share
5.625.274.513.893.212.79
Buildings
-1,5981,3641,2911,004683.76
Machinery
-1,1961,1741,001843.34722.34
Construction In Progress
-83.78228.58175.12239.85358.64